IMPACT-FH Study for Implementing Innovative Family Communication and Cascade Testing Strategies for Familial Hypercholesterolemia

被引:2
作者
Jones, Laney K. [1 ,2 ]
Campbell-Salome, Gemme [1 ,3 ]
Walters, Nicole L. [1 ]
Brangan, Andrew [1 ]
Morgan, Kelly M. [1 ]
Tricou, Eric P. [4 ]
Mills, Zoe T. Lindsey [1 ]
McGowan, Mary P. [4 ]
Gidding, Samuel S. [1 ]
Johns, Alicia M. [5 ]
Kirchner, H. Lester [3 ]
Rahm, Alanna Kulchak [1 ]
Sturm, Amy C. [1 ,2 ,6 ]
机构
[1] Geisinger, Res Inst, Dept Genom Hlth, Danville, PA USA
[2] Geisinger, Heart & Vasc Inst, Danville, PA USA
[3] Geisinger, Res Inst, Dept Populat Hlth Sci, Danville, PA USA
[4] Family Heart Fdn, Pasadena, CA USA
[5] Geisinger, Res Inst, Biostat Core, Danville, PA USA
[6] 23andMe, Sunnyvale, CA USA
来源
JACC-ADVANCES | 2024年 / 3卷 / 09期
基金
美国国家卫生研究院;
关键词
cascade testing; family communication; familial hypercholesterolemia; implementation strategies; RELATIVES; CARE;
D O I
10.1016/j.jacadv.2024.101198
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Relatives of probands diagnosed with familial hypercholesterolemia (FH) should undergo cascade testing for FH. OBJECTIVES The purpose of this study was to evaluate probands'choices of innovative strategies to communicate their FH result with relatives and facilitate cascade testing uptake. METHODS Probands with an FH genetic result from the MyCode Community Health Initiative could choose to share their FH result with adult blood relatives via the Family and Healthcare Professional Packet (packet), family sharing and cascade chatbots (chatbot), and/or FH Outreach and Support Program (direct contact). Cascade testing uptake was measured as reported completion of genetic or cholesterol testing. Generalized estimating equations models were used to identify factors associated with testing. RESULTS A total of 175 probands received an FH result, median age was 58.9 (IQR: 44.9-69.3) years, and 58.9% were female. Probands shared information about 1,915 adult and 163 minor relatives (11.9 relatives per proband). Seventy percent of probands (121/175) selected at least one strategy for at least one adult relative. An average of 1.2 strategies was selected per adult relative. Cascade testing was completed for 26.6% (144/541) of adults with at least one strategy selected, 2.4% (33/1,374) of adults without a strategy selected, and 25.2% (41/163) of minor relatives. Factors associated with increased cascade testing uptake were selection of at least one strategy (6.32 higher odds), specifically, selection of direct contact (16.78 higher odds). CONCLUSIONS Strategies implemented improved FH cascade testing uptake compared to previous estimates and in families where no strategy was selected. Overall uptake remains insufficient, which can be attributed to probands reluctance to select a strategy for many relatives. (JACC Adv. 2024;3:101198) (c) 2024 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页数:12
相关论文
共 28 条
[1]   Genetic identification of familial hypercholesterolemia within a single US health care system [J].
Abul-Husn, Noura S. ;
Manickam, Kandamurugu ;
Jones, Laney K. ;
Wright, Eric A. ;
Hartzel, Dustin N. ;
Gonzaga-Jauregui, Claudia ;
O'Dushlaine, Colm ;
Leader, Joseph B. ;
Kirchner, H. Lester ;
Lindbuchler, D'Andra M. ;
Barr, Marci L. ;
Giovanni, Monica A. ;
Ritchie, Marylyn D. ;
Overton, John D. ;
Reid, Jeffrey G. ;
Metpally, Raghu P. R. ;
Wardeh, Amr H. ;
Borecki, Ingrid B. ;
Yancopoulos, George D. ;
Baras, Aris ;
Shuldiner, Alan R. ;
Gottesman, Omri ;
Ledbetter, David H. ;
Carey, David J. ;
Dewey, Frederick E. ;
Murray, Michael F. .
SCIENCE, 2016, 354 (6319)
[2]   Cascade screening based on genetic testing is cost-effective: Evidence for the implementation of models of care for familial hypercholesterolemia [J].
Ademi, Zanfina ;
Watts, Gerald F. ;
Pang, Jing ;
Sijbrands, Eric J. G. ;
van Bockxmeer, Frank M. ;
O'Leary, Peter ;
Geelhoed, Elizabeth ;
Liew, Danny .
JOURNAL OF CLINICAL LIPIDOLOGY, 2014, 8 (04) :390-400
[3]   A randomized controlled trial of genetic testing and cascade screening in familial hypercholesterolemia [J].
Ajufo, Ezimamaka ;
DeGoma, Emil M. ;
Raper, Anna ;
Yu, Kristen Dilzell ;
Cuchel, Marina ;
Rader, Daniel J. .
GENETICS IN MEDICINE, 2021, 23 (09) :1697-1704
[4]   Familial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering Medication [J].
Benn, Marianne ;
Watts, Gerald F. ;
Tybjaerg-Hansen, Anne ;
Nordestgaard, Borge G. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (11) :3956-3964
[5]   Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia [J].
Bhatnagar, D ;
Morgan, J ;
Siddiq, S ;
Mackness, MI ;
Miller, JP ;
Durrington, PN .
BRITISH MEDICAL JOURNAL, 2000, 321 (7275) :1497-1500A
[6]   Clinical outcomes of a genomic screening program for actionable genetic conditions [J].
Buchanan, Adam H. ;
Kirchner, H. Lester ;
Schwartz, Marci L. B. ;
Kelly, Melissa A. ;
Schmidlen, Tara ;
Jones, Laney K. ;
Hallquist, Miranda L. G. ;
Rocha, Heather ;
Betts, Megan ;
Schwiter, Rachel ;
Butry, Loren ;
Lazzeri, Amanda L. ;
Frisbie, Lauren R. ;
Rahm, Alanna Kulchak ;
Hao, Jing ;
Willard, Huntington F. ;
Martin, Christa L. ;
Ledbetter, David H. ;
Williams, Marc S. ;
Sturm, Amy C. .
GENETICS IN MEDICINE, 2020, 22 (11) :1874-1882
[7]   Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia [J].
Campbell-Salome, Gemme ;
Jones, Laney K. ;
Walters, Nicole L. ;
Morgan, Kelly M. ;
Brangan, Andrew ;
Ladd, Ilene G. ;
McGowan, Mary P. ;
Wilemon, Katherine ;
Schmidlen, Tara J. ;
Simmons, Emilie ;
Schwartz, Marci L. B. ;
McMinn, Megan N. ;
Tricou, Eric ;
Rahm, Alanna K. ;
Ahmed, Catherine D. ;
Sturm, Amy C. .
BMC HEALTH SERVICES RESEARCH, 2023, 23 (01)
[8]   Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis Identification Methods, Patient Activation, and Cascade Testing for Familial Hypercholesterolemia [J].
Campbell-Salome, Gemme ;
Jones, Laney K. ;
Masnick, Max F. ;
Walton, Nephi A. ;
Ahmed, Catherine D. ;
Buchanan, Adam H. ;
Brangan, Andrew ;
Esplin, Edward D. ;
Kann, David G. ;
Ladd, Ilene G. ;
Kelly, Melissa A. ;
Kindt, Iris ;
Kirchner, H. Lester ;
McGowan, Mary P. ;
McMinn, Megan N. ;
Morales, Ana ;
Myers, Kelly D. ;
Oetjens, Matthew T. ;
Rahm, Alanna Kulchak ;
Schmidlen, Tara J. ;
Sheldon, Amanda ;
Simmons, Emilie ;
Snir, Moran ;
Strande, Natasha T. ;
Walters, Nicole L. ;
Wilemon, Katherine ;
Williams, Marc S. ;
Gidding, Samuel S. ;
Sturm, Amy C. .
CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2021, 14 (01) :E003120
[9]   The Geisinger MyCode community health initiative: an electronic health record-linked biobank for precision medicine research [J].
Carey, David J. ;
Fetterolf, Samantha N. ;
Davis, Daniel ;
Faucett, William A. ;
Kirchner, H. Lester ;
Mirshahi, Uyenlinh ;
Murray, Michael F. ;
Smelser, Diane T. ;
Gerhard, Glenn S. ;
Ledbetter, David H. .
GENETICS IN MEDICINE, 2016, 18 (09) :906-913
[10]   Limitations and Pitfalls of Using Family Letters to Communicate Genetic Risk: a Qualitative Study with Patients and Healthcare Professionals [J].
Dheensa, Sandi ;
Lucassen, Anneke ;
Fenwick, Angela .
JOURNAL OF GENETIC COUNSELING, 2018, 27 (03) :689-701